摘要
这篇综述系统的审查了关于在多种癌症中热休克蛋白(Hsp)Hsp27、Hsp60、Hsp70和Hsp90的预后意义的文献和数据。我们的文献分析显示现有的数据对于Hsp的预后意义的描述相互矛盾。这种结果可能是由于癌症研究中存在的生理差异和在评估热休克蛋白时的方法学差异。因为它们高度表达从而使肿瘤细胞避免细胞凋亡而死亡,所以热休克蛋白在癌症发展过程中发挥着重要作用。因此,热休克蛋白的抑制目前是对抗癌症的一种有吸引力的潜在治疗方案。
关键词: 癌症,热休克蛋白,热休克蛋白27,热休克蛋白60,热休克蛋白70,热休克蛋白90,预后指标
Current Cancer Drug Targets
Title:Heat Shock Proteins as Prognostic Markers of Cancer
Volume: 14 Issue: 8
Author(s): Evgeniya V. Kaigorodova and Mariya V. Bogatyuk
Affiliation:
关键词: 癌症,热休克蛋白,热休克蛋白27,热休克蛋白60,热休克蛋白70,热休克蛋白90,预后指标
摘要: This review systematically examines the literature and data on the prognostic significance of heat shock proteins (heat shock protein - Hsp) Hsp27, Hsp60, Hsp70, Hsp90 in various cancers. Our analysis of the literature showed that the existing data are contradictory with regard to the prognostic significance of Hsp. This result may be due to biological differences of the carcinomas studied and methodological differences in the assessment of heat shock proteins. Heat shock proteins play a significant role in the development of cancer, as they are highly expressed and thus allow tumor cells to escape apoptotic death. Therefore, the inhibition of Hsps is currently an attractive potential therapeutic approach against cancer.
Export Options
About this article
Cite this article as:
Kaigorodova V. Evgeniya and Bogatyuk V. Mariya, Heat Shock Proteins as Prognostic Markers of Cancer, Current Cancer Drug Targets 2014; 14 (8) . https://dx.doi.org/10.2174/1568009614666140926122846
DOI https://dx.doi.org/10.2174/1568009614666140926122846 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Roles of Calcium and Tyrosine Kinases in the Pathogenesis of Type 2 Diabetes Mellitus
Current Enzyme Inhibition Overview of Angiogenesis and the use of Bevacizumab in Patients with Malignant Gliomas
Current Signal Transduction Therapy Expression, Regulation, and Role of an Oligopeptide Transporter: PEPT1 in Tumors
Current Medicinal Chemistry Mucoadhesive Vaginal Drug Delivery Systems
Recent Patents on Drug Delivery & Formulation Recents Patents for Isolating, Delivering and Tracking Adult Stem Cells in Regenerative Medicine
Recent Patents on Drug Delivery & Formulation Antimicrobial Peptides and Peptaibols, Substitutes for Conventional Antibiotics
Current Pharmaceutical Design miR-21, An Oncogenic Target miRNA for Cancer Therapy: Molecular Mechanisms and Recent Advancements in Chemo and Radio-resistance
Current Gene Therapy Multi-Nuclear Platinum Drugs: A New Paradigm in Chemotherapy
Current Medicinal Chemistry - Anti-Cancer Agents Contemporary Review of Drugs Used to Treat Obesity
Cardiovascular & Hematological Agents in Medicinal Chemistry Alternative Splicing: A Promising Target for Pharmaceutical Inhibition of Pathological Angiogenesis?
Current Pharmaceutical Design Benzopyran Derivatives as Cardio-selective ATP-sensitive Potassium Channel Openers: A Review
Mini-Reviews in Medicinal Chemistry Hitting the Golden TORget: Curcumin’s Effects on mTOR Signaling
Anti-Cancer Agents in Medicinal Chemistry Application of Bacterial Nanocellulose in Cancer Drug Delivery: A Review
Current Pharmaceutical Design Using Pharmacologic Data to Plan Clinical Treatments for Patients with Peritoneal Surface Malignancy
Current Drug Discovery Technologies Bladder Cancer: Update on Risk Factors, Molecular and Ultrastructural Patterns
Current Medicinal Chemistry Drug Delivery Systems and Combination Therapy by Using Vinca Alkaloids
Current Topics in Medicinal Chemistry Targeted Gene Therapy for Ovarian Cancer
Current Gene Therapy Competition Between Tumor and Mononuclear Phagocyte System Causing the Low Tumor Distribution of Nanoparticles and Strategies to Improve Tumor Accumulation
Current Drug Delivery Intranasal Drug Delivery for Brain Targeting
Current Drug Delivery Looking at Drug Resistance Mechanisms for Microtubule Interacting Drugs: Does TUBB3 Work?
Current Cancer Drug Targets